I was wondering if anyone approached Takeda with the question if the Omontys drug will be addressed during the earnings call?
Maybe if this has not happened yet maybe it would be a smart move to make.
I'm mostly on the QCOR board and two investors there had a meeting with someone from investor relations and they got to ask questions and the person from investor relations would address some questions to the QCOR management for their upcoming earnings call.
So maybe we should do something similar here also?
Because it would suck if the Takeda earnings call did not mention anything about Omontys.
Takeda is in the position to shed more light on the investigation, it would be nice to hear SOMETHING.
Because of the time difference the earnings call, live that is, might be in the middle of the night U.S. time. Though I understand what you are saying. I have been reading posts lately on QCOR because of the fight between EXPtrader/Maxdad and some posters who accuse them of pumping and dumping AFFY. I believe the thesis of the posters is wrong in that regard. The drop has more to do with the negative articles posted the last few weeks on SA seemingly to drive down the price.